Gentamicin Targeting Human Hemoglobin Induces Methemoglobin Formation and Decreases Oxygen Affinity: A Molecular Mechanism of Hematologic Toxicity
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177760 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Peilin Shu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Air Force Medical Center, Air Force Medical University, Beijing 100142, China. Hauptthemen laut MEDLINE: Gentamicins, Oxygen, Methemoglobin, Hemoglobins. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The nephrotoxicity and ototoxicity of Gentamicin have been extensively investigated; however, whether they induce hematotoxicity remains unclear. This study aimed to explore the binding of Gentamicin to adult hemoglobin (HbA) and its toxicological implications. The effect of Gentamicin on HbA oxidation was assessed by quantifying methemoglobin (MetHb) formation via a four-wavelength spectrophotometric method, and scavenger rescue assays were employed to elucidate the oxidative mechanism. Alterations in the oxygen-carrying capacity of both HbA and RBCs were evaluated through the acquisition of oxygen equilibrium curves and oxygen dissociation assays. The binding affinity between Gentamicin and HbA was determined by surface plasmon resonance (SPR). Furthermore, the influence of Gentamicin on the secondary and tertiary structures of HbA was examined by microfluidic modulation spectroscopy (MMS) and UV–visible absorption spectroscopy, respectively. Molecular docking was employed to predict the binding sites of Gentamicin on HbA. Molecular dynamics simulations verified the stability of the binding. Gentamicin promoted HbA autoxidation, elevating MetHb levels, and reduced the oxygen affinity of HbA. Gentamicin-promoted HbA autoxidation is primarily mediated by both direct heme-pocket perturbation and H2O2/iron-dependent amplification. SPR confirmed concentration-dependent specific binding between Gentamicin and HbA. MMS indicated no alteration in HbA secondary structure; however, UV–visible spectroscopy revealed that Gentamicin attenuated the Soret band, converted the oxyhemoglobin double-peak to a singlet, and generated a new band at 630 nm. Molecular docking predicted that Gentamicin binds β-chain residues via hydrogen, carbon–hydrogen, and hydrophobic interactions. This study reveals that Gentamicin exerts hematological effects in vitro. By binding to specific sites on HbA, Gentamicin affects the tertiary structure of HbA, promotes heme oxidation, ultimately increases MetHb content (oxidative damage), and decreases its oxygen-carrying capacity (functional impairment).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Air Force Medical Center, Air Force Medical University, Beijing 100142, China.
- School of Integrated Circuits, Beijing University of Technology, Beijing 100124, China.
- Academy of Military Medical Sciences, No. 27 Taiping Road, Haidian, Beijing 100850, China.
ORCID-Profile: Pengfei Wang, Lian Zhao
Zitieren
APA
Shu, P., Wang, P., Li, W., Gu, B., Zheng, Y., Wang, Y., Yang, M., & Zhao, L. (2026). Gentamicin Targeting Human Hemoglobin Induces Methemoglobin Formation and Decreases Oxygen Affinity: A Molecular Mechanism of Hematologic Toxicity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177760
Vancouver
Shu P, Wang P, Li W, Gu B, Zheng Y, Wang Y, et al. Gentamicin Targeting Human Hemoglobin Induces Methemoglobin Formation and Decreases Oxygen Affinity: A Molecular Mechanism of Hematologic Toxicity. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177760
BibTeX
@article{Shu2026,
author = {Shu, Peilin and Wang, Pengfei and Li, Wencong and Gu, Baichuan and Zheng, Yuanjing and Wang, Ying and Yang, Minghao and Zhao, Lian},
title = {Gentamicin Targeting Human Hemoglobin Induces Methemoglobin Formation and Decreases Oxygen Affinity: A Molecular Mechanism of Hematologic Toxicity},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177760}
}
EUVIMED